3,395 Shares in Amdocs Limited (NASDAQ:DOX) Purchased by Verdence Capital Advisors LLC

Verdence Capital Advisors LLC purchased a new position in shares of Amdocs Limited (NASDAQ:DOXFree Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 3,395 shares of the technology company’s stock, valued at approximately $298,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of DOX. Acadian Asset Management LLC bought a new stake in shares of Amdocs during the third quarter worth approximately $96,934,000. Invesco Ltd. boosted its holdings in shares of Amdocs by 31.0% during the third quarter. Invesco Ltd. now owns 2,629,346 shares of the technology company’s stock worth $222,153,000 after acquiring an additional 621,962 shares during the period. Qube Research & Technologies Ltd boosted its holdings in shares of Amdocs by 333.7% during the third quarter. Qube Research & Technologies Ltd now owns 449,788 shares of the technology company’s stock worth $38,003,000 after acquiring an additional 346,071 shares during the period. Meitav Investment House Ltd. boosted its holdings in shares of Amdocs by 2,132.9% during the third quarter. Meitav Investment House Ltd. now owns 299,214 shares of the technology company’s stock worth $25,609,000 after acquiring an additional 285,814 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its holdings in shares of Amdocs by 39.2% during the third quarter. The Manufacturers Life Insurance Company now owns 796,767 shares of the technology company’s stock worth $67,319,000 after acquiring an additional 224,518 shares during the period. Institutional investors own 92.02% of the company’s stock.

Analyst Ratings Changes

DOX has been the subject of a number of analyst reports. Barclays lifted their price target on shares of Amdocs from $105.00 to $115.00 and gave the company an “overweight” rating in a research report on Thursday, February 8th. StockNews.com downgraded shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Friday, March 15th. Finally, Citigroup lifted their price target on shares of Amdocs from $96.00 to $104.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Amdocs currently has an average rating of “Buy” and an average price target of $108.60.

Get Our Latest Stock Report on Amdocs

Amdocs Stock Up 0.3 %

Shares of DOX opened at $86.57 on Wednesday. Amdocs Limited has a one year low of $78.38 and a one year high of $99.75. The company has a market cap of $10.18 billion, a P/E ratio of 18.54, a P/E/G ratio of 1.40 and a beta of 0.69. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.29 and a quick ratio of 1.29. The firm has a 50 day simple moving average of $89.93 and a two-hundred day simple moving average of $87.33.

Amdocs (NASDAQ:DOXGet Free Report) last announced its quarterly earnings data on Tuesday, February 6th. The technology company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.40 by $0.16. Amdocs had a net margin of 11.30% and a return on equity of 17.79%. The business had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.24 billion. During the same period in the previous year, the business earned $1.33 earnings per share. The company’s revenue was up 5.0% on a year-over-year basis. Research analysts forecast that Amdocs Limited will post 5.87 EPS for the current fiscal year.

Amdocs Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be given a dividend of $0.479 per share. This is an increase from Amdocs’s previous quarterly dividend of $0.44. This represents a $1.92 annualized dividend and a yield of 2.21%. The ex-dividend date of this dividend is Wednesday, March 27th. Amdocs’s payout ratio is currently 40.90%.

About Amdocs

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Further Reading

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.